Table 1

Characteristics of study participants
Age, years median (IQR) Female sex, number (%) Faecal calprotectin, μg/g, median (IQR) ESSDAI/DAS28-CRP(3), median (IQR)
Systemic sclerosis (n = 93) 62 (51 to 70) 77 (83) 110 (42 to 210) NA
Primary Sjögren’s syndrome (n = 44) 61 (55 to 68) 43 (98) 41 (<30 to 118) 7 (1 to 10)
Rheumatoid arthritis (n = 24) 66 (55 to 69) 20 (83) 43 (<30 to 93) 3.1 (2.1 to 3.9)
Healthy controls (n = 21) 56 (47 to 58) 17 (81) <30 (<30 to 56) NA

DAS28-CRP(3), Disease Activity Score 28 based on CRP and 3 variables; ESSDAI, EULAR Sjögren’s Disease Activity Index; IQR, interquartile range; NA, not applicable.

Andréasson et al.

Andréasson et al. Arthritis Research & Therapy 2014 16:R46   doi:10.1186/ar4475

Open Data